Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trial

Abstract Aims The long‐term outcomes of the intracoronary delivery of autologous bone marrow‐derived cells (BMCs) after acute myocardial infarction are not well established. Following the promising 1 year results of the REGENERATE‐AMI trial (despite it not achieving its primary endpoint), this paper...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Anthony Mathur, Doo Sun Sim, Fizzah Choudry, Jessry Veerapen, Martina Colicchia, Tymoteusz Turlejski, Mohsin Hussain, Stephen Hamshere, Didier Locca, Roby Rakhit, Tom Crake, Jens Kastrup, Samir Agrawal, Daniel A. Jones, John Martin
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Oxford University Press 2022-04-01
Cyfres:	ESC Heart Failure
Pynciau:	Myocardial infarction Stem cells Percutaneous coronary intervention
Mynediad Ar-lein:	https://doi.org/10.1002/ehf2.13786
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!